Related Experiment Video
Updated: Jan 14, 2026
Imaging Analysis of Neuron to Glia Interaction in Microfluidic Culture Platform MCP-based Neuronal Axon and Glia Co-culture System
Published on: October 14, 2012
Decoding the Hex-GM2-MGL2 axis in microglia-neuron crosstalk
Dennis-Dominik Rosmus1, Bahareh Ajami2
1Institute of Anatomy, Leipzig University, Leipzig, Germany; Cellular Neuroanatomy, Chair of Anatomy and Cell Biology, Institute of Theoretical Medicine, University of Augsburg, Augsburg, Germany; Department of Neurology, University of Leipzig Medical Center, Leipzig, Germany.
Malfunctioning microglia-neuron enzyme delivery systems drive neurodegeneration in Sandhoff disease. Hematopoietic replacement therapy offers a promising treatment for this and other neurodegenerative disorders.
Area of Science:
- Neuroscience
- Genetics
- Immunology
Background:
- Neurodegeneration involves impaired communication between central nervous system (CNS) cells.
- Sandhoff disease is a fatal neurodegenerative disorder caused by genetic mutations.
Purpose of the Study:
- To investigate the role of intercellular communication in neurodegeneration.
- To identify therapeutic targets for Sandhoff disease and related disorders.
Main Methods:
- Analysis of microglia-neuron interactions in a mouse model of Sandhoff disease.
- Evaluation of hematopoietic stem cell transplantation as a therapeutic intervention.
Main Results:
- A dysfunctional microglia-neuron enzyme delivery system was identified as a key driver of Sandhoff disease pathology.
- Hematopoietic replacement therapy successfully corrected the enzyme deficiency and ameliorated disease symptoms.
Conclusions:
- The study highlights the critical role of intercellular enzyme delivery in maintaining CNS health.
- Hematopoietic replacement therapy presents a viable therapeutic strategy for Sandhoff disease and potentially other neurodegenerative conditions.
